None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 20 years of age 2. malignant hilar biliary obstruction of Bismuth type II or higher, causing jaundice 3. cholangiocarcinoma or gallbladder cancer or metastatic cancer 4. unsuitable for curative resection due to locally advanced stage, metastasis, or high surgical risk 5. life expectancy > 4 months
Exclusion criteria
Exclusion criteria: 1. hepatocellular carcinoma 2. surgically altered upper gastrointestinal anatomy following hepatobiliary or gastric surgery except cholecystectomy 3. uncontrolled coagulopathy (International normalized ratio > 1.5 or platelet count < 50,000 /mm3) 4. liver atrophy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Stent dysfunction rate | — |
Secondary
| Measure | Time frame |
|---|---|
| early advere event;late adverse event | — |
Countries
Korea, Republic of
Contacts
Ajou University Hospital